On the one hand, breast cancers evolved resistance mechanisms, such as RB1 inactivation or ESR1 gain-of-function changes, to deregulate cell cycle control and drive aggressive cell growth and proliferation. The gene discussed is RB1; the disease is breast carcinoma.